MYC and breast carcinoma: Co-amplifications of other driver loci in breast cancer are observed, for example chr20:ZNF217 and chr8:MYC is seen in 18 samples (P = 1e−04) and chr20:ZNF217 and chr8:ZNF703 in 11 samples (P = 9e−03) (supplementary Table S1, available at Annals of Oncology online).